BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 31830135)

  • 1. Shigella sonnei infection of zebrafish reveals that O-antigen mediates neutrophil tolerance and dysentery incidence.
    Torraca V; Kaforou M; Watson J; Duggan GM; Guerrero-Gutierrez H; Krokowski S; Hollinshead M; Clarke TB; Mostowy RJ; Tomlinson GS; Sancho-Shimizu V; Clements A; Mostowy S
    PLoS Pathog; 2019 Dec; 15(12):e1008006. PubMed ID: 31830135
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Watson JL; Sanchez-Garrido J; Goddard PJ; Torraca V; Mostowy S; Shenoy AR; Clements A
    mBio; 2019 Dec; 10(6):. PubMed ID: 31848280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of a stable and non-resistant bivalent vaccine candidate strain against Shigella flexneri 2a and Shigella sonnei.
    Rui X; Xu Y; Wan H; Su G; Huang C
    Chin J Biotechnol; 1996; 12(2):89-97. PubMed ID: 8988355
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Willis AR; Torraca V; Gomes MC; Shelley J; Mazon-Moya M; Filloux A; Lo Celso C; Mostowy S
    mBio; 2018 Jun; 9(3):. PubMed ID: 29946048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of the virulence plasmid by
    Wu BC; Olivia NA; Tembo JM; He YX; Zhang YM; Xue Y; Ye CL; Lv Y; Li WJ; Jiang LY; Huo XX; Sun ZY; Chen ZJ; Qin JC; Li AY; Park CG; Klena JD; Ding HH; Chen T
    J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33591245
    [No Abstract]   [Full Text] [Related]  

  • 6. [Development and use of solid-phase test-systems for the detection of O-antigen of Shigella sonnei and Shigella flexneri].
    Triasuchev IO; Davydov AG; Burkin VS; Pokrovskiĭ VI; Pukhova TV
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Jun; (6):74-7. PubMed ID: 2477970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shigella sonnei: virulence and antibiotic resistance.
    Shad AA; Shad WA
    Arch Microbiol; 2021 Jan; 203(1):45-58. PubMed ID: 32929595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of prior infection with virulent Shigella flexneri 2a on the resistance of monkeys to subsequent infection with Shigella sonnei.
    Formal SB; Oaks EV; Olsen RE; Wingfield-Eggleston M; Snoy PJ; Cogan JP
    J Infect Dis; 1991 Sep; 164(3):533-7. PubMed ID: 1869840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenicity and virulence of
    Matanza XM; Clements A
    Virulence; 2023 Dec; 14(1):2280838. PubMed ID: 37994877
    [No Abstract]   [Full Text] [Related]  

  • 10. Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children.
    Passwell JH; Ashkenazi S; Harlev E; Miron D; Ramon R; Farzam N; Lerner-Geva L; Levi Y; Chu C; Shiloach J; Robbins JB; Schneerson R;
    Pediatr Infect Dis J; 2003 Aug; 22(8):701-6. PubMed ID: 12913770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissecting the contribution of O-Antigen and proteins to the immunogenicity of Shigella sonnei generalized modules for membrane antigens (GMMA).
    Mancini F; Gasperini G; Rossi O; Aruta MG; Raso MM; Alfini R; Biagini M; Necchi F; Micoli F
    Sci Rep; 2021 Jan; 11(1):906. PubMed ID: 33441861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole genome analysis to detect potential vaccine-induced changes on Shigella sonnei genome.
    Behar A; Fookes MC; Goren S; Thomson NR; Cohen D
    Vaccine; 2015 Jun; 33(26):2978-83. PubMed ID: 25936664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative proteomic analysis of Shigella flexneri and Shigella sonnei Generalized Modules for Membrane Antigens (GMMA) reveals highly pure preparations.
    Maggiore L; Yu L; Omasits U; Rossi O; Dougan G; Thomson NR; Saul A; Choudhary JS; Gerke C
    Int J Med Microbiol; 2016 Feb; 306(2):99-108. PubMed ID: 26746581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination with Shigella flexneri 2a conjugate induces type 2a and cross-reactive type 6 antibodies in humans but not in mice.
    Farzam N; Ramon-Saraf R; Banet-Levi Y; Lerner-Geva L; Ashkenazi S; Kubler-Kielb J; Vinogradov E; Robbins JB; Schneerson R
    Vaccine; 2017 Sep; 35(37):4990-4996. PubMed ID: 28797729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum IgG antibody responses to Shigella invasion plasmid-coded antigens detected by immunoblot.
    Li A; Zhao CR; Ekwall E; Lindberg AA
    Scand J Infect Dis; 1994; 26(4):435-45. PubMed ID: 7984976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Determination of the O antigen of Shigella sonnei by a competitive immunoenzyme method].
    Voronov AV; Sazykin AIu; Vengerov IuIu; Serebriakov MIu; Malov VA
    Antibiot Khimioter; 1988 Jan; 33(1):43-6. PubMed ID: 2454084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationalizing the design of a broad coverage Shigella vaccine based on evaluation of immunological cross-reactivity among S. flexneri serotypes.
    Citiulo F; Necchi F; Mancini F; Rossi O; Aruta MG; Gasperini G; Alfini R; Rondini S; Micoli F; Rappuoli R; Saul A; Martin LB
    PLoS Negl Trop Dis; 2021 Oct; 15(10):e0009826. PubMed ID: 34644291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and immunogenicity of Shigella sonnei and Shigella flexneri 2a O-specific polysaccharide conjugates in children.
    Ashkenazi S; Passwell JH; Harlev E; Miron D; Dagan R; Farzan N; Ramon R; Majadly F; Bryla DA; Karpas AB; Robbins JB; Schneerson R
    J Infect Dis; 1999 Jun; 179(6):1565-8. PubMed ID: 10228084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'O'-antigens are essential virulence factors of Shigella sonnei and Shigella dysenteriae 1.
    Binns MM; Vaughan S; Timmis KN
    Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Jun; 181(1-2):197-205. PubMed ID: 2413650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Rising Dominance of Shigella sonnei: An Intercontinental Shift in the Etiology of Bacillary Dysentery.
    Thompson CN; Duy PT; Baker S
    PLoS Negl Trop Dis; 2015; 9(6):e0003708. PubMed ID: 26068698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.